Propionic Acidemia Market Players:
- Cardiva Grifols SA
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- CSL Behring
- Octapharma AG
- Sanquin
- Kedrion SpA
- Shire
- China Biologic Products Holdings Inc.
- Teva Pharmaceuticals
- Wellona Pharma
- Merck
- AdvaCare Pharma
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of propionic acidemia is assessed at USD 1.39 billion.
The global propionic acidemia market size was valued at over USD 1.34 billion in 2025 and is expected to register a CAGR of over 4.2%, exceeding USD 2.02 billion revenue by 2035.
North America propionic acidemia market is expected to capture 35% share, driven by improved healthcare infrastructure and FDA approvals, forecast period 2026–2035.
Key players in the market include China Biologic Products Holdings Inc., Teva Pharmaceuticals, Wellona Pharma, Merck, AdvaCare Pharma.
